• Search
  • Login
  • Register
Menu
  • BJMO
  • Home
  • News
  • CongressUpdate
  • Specials
  • Links
All
  • All
  • BJMO articles
  • Blog articles
  • Specials
Forgot Password? Not a member yet? Register here
News > ASCO 2019

Category

All
  • Pharma News
  • Health of Tomorrow
  • Opinion
  • Art Corner
  • Fundraising
  • Prevention
  • Science
  • Clinical Practice
  • Corona
  • Cancer trials
  • Healthy Living
  • Medical Research
  • Art on View
  • Viewpoints
  • Therapy
  • Health Innovation
  • Podcasts
  • Editor's pick
  • Publishing News
  • Special
  • BSMO Meeting 2021
  • Covid-19
  • EADO 2021

ASCO 2019

NEOSTAR: pre-surgical checkpoint inhibition effective in early stage lung cancer

Read more
subscribe Latest issue All issues Newsletters
Index latest issue
  • The Belgian Virtual Tumourbank: Residual tumour samples with high quality data
  • Rethinking the reimbursement of innovative medicines in oncology: Looking beyond overall survival
  • Individualising radiation therapy decisions in breast cancer patients based on tumour-infiltrating lymphocytes and genomic biomarkers
  • Early-onset cancers: Incidence trends in Belgium, 2004–2020
  • Improving dysphagia care in head and neck cancer patients treated with radiotherapy
  • Journal Scan
  • New oncology reimbursements in Belgium
ASCO 2019

Ramucirumab plus erlotinib improves progression-free survival in EGFR-positive lung cancer

Read more
ASCO 2019

FOLFOXIRI + bevacizumab shows progression-free survival benefit in mCRC patients

Read more
ASCO 2019

Pembrolizumab increases survival rate for certain people with advanced NSC lung cancer

Read more
Top

Join our newsletter

  • This field is for validation purposes and should be left unchanged.
  • About BJMO
  • Ads & sponsoring
  • Vacancies
  • Disclaimer
  • Privacy
  • Contact

BJMO is published by Ariez International BV, Westzijde 22, 1506 EE Zaandam, The Netherlands

© BJMO 2023